Healthy Clinical Trial
Official title:
The Reliability and Validity of the Turkish Version of the Smartphone Impact Scale
NCT number | NCT04337775 |
Other study ID # | 3278 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | May 7, 2020 |
Est. completion date | July 27, 2020 |
Verified date | July 2020 |
Source | Istanbul University-Cerrahpasa |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Smartphone Impact Scale (SIS) was originally developed in English to determine the cognitive, affective, social, and behavioral impacts of smartphones in everyday life. The purpose of this study was to translate and cross-culturally adapt the SIS instrument into Turkish and investigate its psychometric properties.
Status | Completed |
Enrollment | 264 |
Est. completion date | July 27, 2020 |
Est. primary completion date | June 8, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 35 Years |
Eligibility |
Inclusion Criteria: - Aged between 18 and 35 years - Having a smartphone that was connected to the Internet for at least 6 months - Being a volunteer to participate Exclusion Criteria: - Having cognitive impairment - Having disabilities in understanding, speaking and reading Turkish |
Country | Name | City | State |
---|---|---|---|
Turkey | Istanbul University-Cerrahpasa | Istanbul | Bakirkoy |
Lead Sponsor | Collaborator |
---|---|
Istanbul University-Cerrahpasa |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Smartphone Impact Scale | The Smartphone Impact Scale is a reliable and scale for evaluating cognitive, affective, social, and behavioral impacts of smartphones in everyday life. It assesses loss of control of smartphone use ,nomophobia, smartphone-mediated communication, emotion regulation through smartphone usage, smartphone support to romantic relationships, smartphone tasks support, and awareness of smartphone negative impact. A high score in the subscales shows a higher negative impact of smartphone on cognitive, affective, social, and behavioral aspects. | Baseline (First assessment) | |
Secondary | Smartphone Impact Scale | The Smartphone Impact Scale is a reliable and scale for evaluating cognitive, affective, social, and behavioral impacts of smartphones in everyday life. It assesses loss of control of smartphone use ,nomophobia, smartphone-mediated communication, emotion regulation through smartphone usage, smartphone support to romantic relationships, smartphone tasks support, and awareness of smartphone negative impact. A high score in the subscales shows a higher negative impact of smartphone on cognitive, affective, social, and behavioral aspects. | Within a 5-to-7-day period after the first assessment (Second assessment) | |
Secondary | Smartphone Addiction Scale | Smartphone Addiction Scale (SAS) is a self-reported scale developed by Kwon et al. based on internet addiction and the features of smartphones in 20135. The scale consisted of 33 items rated on a 6-point Likert-type scale from 1 to 6. A high total score in the scale, which has no cut-off score, shows a smartphone addiction risk. The Turkish version of SAS (SAS-T), which was previously reported as a reliable instrument, will use in the present study. | Baseline (First assessment) | |
Secondary | Nottingham Health Profile | Nottingham Health Profile is patient-completed questionnaire used to determine and quantify perceived health problems. Composed of 38 items divided into six domains: 1) sleep, 2) mobility, 3) energy, 4) pain, 5) emotional reactions, 6) social isolation. Total Score ranges from 0 (no perceived distress) to 100 (maximum perceived distress). The Turkish version of Nottingham Health Profile, which was previously reported as a reliable and valid instrument, will use in the present study. | Baseline (First assessment) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |